ANDRES MANUEL R CERVANTES RUIPEREZ-rekin lankidetzan egindako argitalpenak (6)

2020

  1. Neoadjuvant treatment for locally advanced unresectable and borderline resectable pancreatic cancer: Oncological outcomes at a single academic centre

    ESMO Open, Vol. 5, Núm. 6

2019

  1. Improving tumour budding evaluation in colon cancer by extending the assessment area in colectomy specimens

    Histopathology, Vol. 75, Núm. 4, pp. 517-525

  2. Low miR200c expression in tumor budding of invasive front predicts worse survival in patients with localized colon cancer and is related to PD-L1 overexpression

    Modern Pathology, Vol. 32, Núm. 2, pp. 306-313

2018

  1. Borderline resectable pancreatic cancer. Challenges and controversies

    Cancer Treatment Reviews, Vol. 68, pp. 124-135

2017

  1. mRNA expression profiles obtained from microdissected pancreatic cancer cells can predict patient survival

    Oncotarget, Vol. 8, Núm. 62, pp. 104796-104805

2014

  1. Implicaciones pronósticas del estudio estandarizado de los márgenes de resección en el cáncer de páncreas

    Cirugia Espanola, Vol. 92, Núm. 8, pp. 532-538